袖状胃切除后转为SADI-S与初次SADI-S的安全性与 prevalence 比较
本研究基于MBSAQIP数据库2020–2021年数据,回顾性比较初次SADI-S(p-SADI-S,488例)与袖状胃切除后转为SADI-S(SG-SADI,295例)的30天严重并发症和死亡率。结果显示SG-SADI占SADI-S手术的37.6%,其严重并发症率(5.7% vs 6.9%,p=0.508)与p-SADI-S无显著差异,多因素分析中SG-SADI并非严重并发症的独立预测因素(OR 0.81,95%CI 0.43–1.52,p=0.514)。
要点
- SG-SADI占SADI-S手术的37.6%,已成为常见术式。
- SG-SADI与p-SADI-S的30天严重并发症率无显著差异。
- 多因素分析显示SG-SADI非严重并发症独立预测因素。
核心结论
- SG-SADI转流术占SADI-S手术的37.6%,其30天严重并发症率与初次SADI-S相似,安全性可接受。
研究设计与样本
- 回顾性队列研究,分析MBSAQIP数据库2020–2021年数据,共纳入783例患者(p-SADI-S 488例,SG-SADI 295例)。
主要发现
- SG-SADI组平均BMI较低(45.1 vs 51.4 kg/m2,p<0.001),手术时间较长(156.7 vs 142.1 min,p<0.001)。
- SG-SADI组严重并发症率为5.7%,p-SADI-S组为6.9%,差异无统计学意义(p=0.508)。
- p-SADI-S组肺炎发生率较高(1.2% vs 0.0%,p<0.001),SG-SADI组再手术率(3.0% vs 3.2%,p=0.861)、再入院率(5.4% vs 5.5%,p=0.948)和死亡率(0.0% vs 0.2%,p=0.437)均无显著差异。
- 多因素分析调整年龄、性别、BMI、合并症和手术时间后,SG-SADI并非严重并发症的独立预测因素(OR 0.81,95%CI 0.43–1.52,p=0.514)。
关键数值与推荐
- SG-SADI组修正手术指征包括体重复增(50.8%)、减重不足(41.0%)、其他(3.0%)、GERD(2.7%)和持续合并症(2.5%)。
临床怎么用
- 对于袖状胃切除后减重失败或体重复增的患者,转为SADI-S的30天严重并发症风险与初次SADI-S相当,可考虑作为修正手术选项。
局限性
- 本研究为回顾性数据库分析,可能存在选择偏倚和未测量混杂因素,且仅纳入2020–2021年数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Conversion from sleeve gastrectomy (SG) to single anastomosis duodeno-ileal bypass (SADI) is becoming increasingly common, but data regarding safety is of these conversions is scarce. As such, the objective of this study was to compare the 30-day rate of serious complications and mortality of primary SADI (p-SADI-S) with SG to SADI (SG-SADI) conversions. METHODS: This retrospective cohort study analyzed the MBSAQIP database. Patients undergoing p-SADI-S and SG-SADI were included. Data collection was limited to 2020 and 2021. A multivariable logistic regression analysis was performed between groups to determine if SG-SADI was an independent predictor of 30-day serious complications or mortality. RESULTS: A total of 783 patients were included in this study, 488 (62.3%) underwent p-SADI-S and 295 (37.6%) underwent SG-SADI. The mean body mass index (BMI) at the time of surgery was lower in the SG-SADI cohort (45.1 vs 51.4 kg/m2, p < 0.001). Indications for revision in the SG-SADI cohort included weight recurrence (50.8%), inadequate weight loss (41.0%), other (3.0%), GERD (2.7%), and persistent comorbidities (2.5%). SG-SADI had longer operative times (156.7 vs 142.1 min, p < 0.001) and was not associated with a higher rate of serious complications (5.7 vs 6.9%, p = 0.508) compared to p-SADI-S. p-SADI-S was associated with a higher rate of pneumonia (1.2 vs 0.0%, p < 0.001), and SG-SADI was not correlated with higher rates of reoperation (3.0 vs 3.2%, p = 0.861), readmission (5.4 vs 5.5%, p = 0.948) and death (0.0 vs 0.2%, p = 0.437). On multivariable analysis, SG-SADI was not independently predictive of serious complications (OR 0.81, 95% CI 0.43 to 1.52, p = 0.514) when adjusting for age, sex, BMI, comorbidities, and operative time. CONCLUSIONS: The prevalence of SG-SADI is high, representing 37.6% of SADI-S procedures. Conversion from sleeve to SADI, is safe, and as opposed to other studies of revisional bariatric surgery, has similar 30-day complication rates to primary SADI-S.
引用
- Barajas-Gamboa JS, Moon S, Romero-Velez G, et al. Primary single anastomosis duodeno-ileal bypass with sleeve gastrectomy (SADI-S) versus sleeve gastrectomy to SADI conversions: a comparison study of prevalence and safety. Surg Endosc. 2023. PMID: 37500921. doi:10.1007/s00464-023-10305-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。